SIFALIMUMAB Drug Record

  • SIFALIMUMAB chembl:CHEMBL1743069

    Alternate Names:

    SIFALIMUMAB
    MEDI-545
    MDX-1103

    Drug Info:

    FDA Approval not approved
    Drug Class monoclonal antibody
    Drug Indications for treatment of systemic lupues erythematosus
    (0 More Sources)

    Publications:

  • SIFALIMUMAB   IFNAR1

    Interaction Score: 2.58

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name sifalimumab, MEDI-545, MDX-1103
    Novel drug target Established target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • SIFALIMUMAB   IFNAR2

    Interaction Score: 2.58

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    TTD

  • TdgClinicalTrial: SIFALIMUMAB

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications for treatment of systemic lupues erythematosus
    Drug Class monoclonal antibody
    FDA Approval not approved

    Publications:

  • TTD: Sifalimumab

    • Version: 2020.06.01

    Alternate Names:
    D05NDR TTD Drug ID

    Drug Info:

    Publications:

  • ChemblDrugs: chembl:CHEMBL1743069

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications: